Denial of treatment for chronic pain is GOING INTERNATIONAL ?

Daphne Bramham: Tougher new regulations promise more agony for chronic pain-sufferers

https://vancouversun.com/opinion/columnists/daphne-bramham-tougher-new-regulations-promise-more-agony-for-chronic-pain-sufferers

One in five Canadians lives with chronic pain, but the cries of an estimated 800,000 British Columbians are not only being ignored, their suffering is being exacerbated by regulators limiting their access to both drugs and treatment.

First, in a move unprecedented in North America, the B.C. College of Physicians and Surgeons imposed mandatory opioid and narcotic prescription limits on doctors in 2016 in an attempt to avoid creating additional addicts and having more prescription drugs sold on the street.

Physicians who don’t comply can be fined up to $100,000 or have their licences revoked.

Now, the college is setting tough regulations for physicians administering pain-management injections.

“I’m enraged,” says Kate Mills, a 33-year-old, palliative care nurse who has been on disability leave for the past 18 months. “People like me are living in chronic, intractable pain and being ignored by doctors who are either too scared or too callous to care.”

She has an uncommon, congenital condition that causes chronic inflammation near her sacroiliac joint and in her lower back, which pushes down on her nerves causing “exquisite pain” down her leg.

Her first doctor essentially fired her, refusing to treat the pain. The next one prescribed Oxycodone to help Mills through until she was able to receive a steroid injection at a clinic, which kept the pain in check for several months.

But by the time the injection’s effects were wearing off, her GP went on extended medical leave. The locum assigned to Mills refused to prescribe her any medication and told her to go to an emergency room where she was given a prescription.

After numerous ER visits, Mills finally found a doctor two weeks ago who is willing to provide medication for her between injections. But he agreed only after Mills signed a contract agreeing that she won’t sell the drugs, will only go to one pharmacy and take the drugs only as prescribed.

She is lucky, though. Her pain management clinic will likely meet the college’s new standards that were developed by an advisory panel over the past three years out of concern about patient safety.

“Increasingly,” the college says on its website, “Procedural pain management is being provided in private clinics and physician offices, but without much guidance on appropriate credentials, settings, techniques and equipment.”

The new regulations would require physicians’ offices or clinics to become accredited facilities with standards on par with ambulatory surgery centres.

That means having tens of thousands of dollars’ worth of equipment including resuscitation carts, high-resolution ultrasound, automated external defibrillators and electronic cardiograms with printout capability.

The college acknowledges that “patients do not require continuous ECG monitoring. However, the cardiac monitoring equipment must be available in the event a patient has an unintended reaction to the procedure.”

The disruption for patients will be huge, according to Dr. Helene Bertrand, a general practitioner, pain researcher and clinical instructor at UBC’s medical school.

She estimates that up to 80 per cent of the offices and clinics where the injections are currently being done won’t measure up and already wait times are up to 18 months.

When the new requirements come into force, Bertrand predicts patients will be waiting anywhere from four to seven years for treatment.

Bertrand herself will have to quit doing prolotherapy, which she has done for the past 18 years on everything from shoulders to necks to spine to ankles. That’s despite the fact she’s never been sued, never had a complaint filed with the college and has published, peer-reviewed research that revealed an 89 per cent success rate among 211 patients in her study group.

(Prolotherapy involves injecting a sugar solution close to injured or painful joints causing inflammation. That inflammation increases the blood supply and deposits collagen on tendons and ligaments helping to repair them.)

The college will not grandfather general practitioners already doing injection therapies. Instead it will restrict general practitioners to knees, ankles and shoulders. All other joint injections must be done by anesthetists or pain specialists.

For Joan Bellamy, that’s a huge step backward.

She’s suffered from chronic pain since 1983 and “undergone the gamut of medical approaches, often with excessive waits: hospital OP (outpatient), pharmacology, neurology, orthopedics, spinal, physiatry and private.”

Since 2000, she’s had multiple injections that have made a difference. But her doctor doesn’t meet the new qualifications.

“I am afraid that without her expertise … that pain will become an intolerable burden, and any search for treatment will result in inconceivable wait times and will debilitate me,” Bellamy wrote in a letter to the college and copied to me.

The near future for pain-sufferers looks grim with most physicians able to offer them little more than over-the-counter painkillers.

Ironically at a time when the provincial medical health officer and others are lobbying hard to have all drugs legalized so that addicts have access to a safe supply, chronic pain-sufferers are being marginalized. For them, it’s more difficult than ever to get what they need.

It’s forcing many of them facing a lifetime of exquisite and unbearable pain to at least contemplate one of two deadly choices: Buy potentially fentanyl-laced street drugs; or worse, ask for medically assisted dying.

Portage woman’s family says she died because she couldn’t get her painkillers

Amputee Dawn Anderson talks about opioid pain reliefPortage woman’s family says she died because she couldn’t get her painkillers

https://www.nwitimes.com/news/special-section/opioids-in-nwi/portage-woman-s-family-says-she-died-because-she-couldn/article_084ea51b-74c5-5566-8049-923c6dc961bd.html

Amanda Latronica says her mom died of a “soft suicide.”

She didn’t put a gun to her head and pull the trigger — but the result was the same.

Earlier this year, Dawn Anderson, Latronica’s mother, went into kidney failure. It was another in a string of health problems that had left Anderson, a 53-year-old former nurse from Portage, severely disabled.

She had two amputated legs and was missing an eye, both complications from Type 1 diabetes.

And she was in extreme pain, she said, because of the opioid crisis.

Anderson was the face of a July 2018 Times story about the plight of chronic pain patients who feel they’re the inadvertent victims of that epidemic. Amid a rash of opioid overdose deaths — caused in part by physicians liberally prescribing the drugs — the U.S. Centers for Disease Control and Prevention in 2016 issued guidelines recommending that doctors not prescribe large doses of opioids, or prescribe them long term, to patients who weren’t at the end of life or undergoing cancer care.

That, along with the Drug Enforcement Administration going after doctors for overprescribing painkillers, left many physicians fearful of dispensing pain meds.

“The safest thing is to err on the side of safety and be overly strict in prescribing,” said Dr. Shaun Kondamuri, a Munster pain management specialist. “So legitimate pain patients are suffering. They may not get medications. They may not get enough medications.”

He said pain medicine prescribing went from one extreme to another, from doctors handing out painkillers like candy to not giving them to people who actually needed them. Many primary care doctors now refer pain patients to specialists because they don’t want to deal with them.

But last month, the CDC published a report saying that doctors were misinterpreting the guidelines. It clarified that the recommendations did not advocate for abruptly tapering or cutting off patients from pain meds, particularly for people already on high dosages.

The original suggestions said physicians should not increase patients to 90 or more milligrams of morphine, or its equivalent, per day. But many doctors incorrectly thought that meant not having any patients on that high a dose.

That was the case for Anderson. She had been on 90 milligrams of morphine, but her doctor reduced her dosage and gave her a shorter-acting form of the medication. That, she said, left her unable to go up and down stairs, to drive, to garden, to function much at all. She tried pain injections, CBD, kratom — but nothing worked.

She told The Times in July that she was tempted to look for a “Dr. Kevorkian type,” someone who would help put her out of her misery.

She found that, her family said, in the form of not seeking medical treatment that would have kept her alive.

Rushed to the hospital

In early March, Anderson’s husband tried calling her at home, but she didn’t answer. He called police to do a wellness check. They found her on the floor, disoriented.

An ambulance took her to the hospital, where doctors confirmed she was in kidney failure. They said dialysis was an option. She refused it.

A few days later, her condition deteriorating, she chose to go home and die peacefully, her family and hospice by her side.

“If she knew she would have had pain medication and wouldn’t have had to suffer, she absolutely would have agreed to do dialysis,” said Latronica, a 29-year-old truck driver from Diamond, Illinois.

“She said, ‘This is my way out.'”

Anderson had organized and led a local Don’t Punish Pain rally last September in Valparaiso. The national founder of that movement, Claudia Merandi, said that despite the CDC’s clarifications, things are actually getting worse for chronic pain patients. That’s because many doctors are increasingly afraid they’ll get arrested if the DEA decides they’re prescribing too many painkillers.

“The fear of retribution is very real, it’s very great, and it needs to stop,” said Merandi, 50, a former stenographer from East Providence, Rhode Island who is on disability because of Crohn’s disease.

She said the one thing that has changed is that chronic pain patients’ voices are being heard. Also, lawmakers are starting to introduce legislation to protect pain patients, doctors and pharmacists who are legitimating using and prescribing painkillers. But it’s still not enough, she said.

Merandi said people in her movement are killing themselves or opting to die rather than seek medical care on a monthly basis, often veterans.

“They’re too weak to fight. They don’t want to fight. What are they going to fight for?” she said. “They’re going to come back into a life of no medication. What’s the point of living? That was Dawn. Dawn didn’t want to live.”

And even if health care providers go back to prescribing more painkillers for legitimate pain patients, it’s already too late for families like Anderson’s.

“Without a doubt, I know she would still be alive if she had the medication she needed,” Latronica said. “That was the only thing that allowed her to live functionally and manageably. When they took it away, that took away her will to live.

“She had three granddaughters and two daughters and a husband. She wanted to live. She tried. She just couldn’t do it any longer.”

Latronica said that even as her mother struggled during her final months, the fight on behalf of other chronic pain patients sustained her, gave her something to be proud of, gave her life.

“The pain community needs justice. My mom needs justice,” Latronica said. “I don’t want her death to be in vain.”

In Memory America’s Fallen

www.youtube.com/watch?v=r8c1JaAhUsw

Is the chronic pain community ON THEIR OWN TO CHANGE THEIR DESTINY ?

Another Pain Organization to Shut Down

www.nationalpainreport.com/another-pain-organization-to-shut-down-8839923.html

Another pain organization apparently is going out of business.

The American Pain Society is filing for bankruptcy and ceasing to exist in its current form.

“It’s a sad day for U.S. pain research, education, advocacy and patient care,” said Stanford’s Beth Darnall, Ph.D., in a tweet this week.

APS is the second pain organization this year to announce it’s shutting down.

The Academy of Integrative Pain announced it was closing down in February. The reasons appear to be similar.

All membership organizations are struggling with the fact that the new generation of doctors are simply joining as previous generations.

“People entering practice after training just aren’t seeing the value in joining organizations. They still want the educational materials and the networking, but much more of that can be done online these days,” said Bob Twillman, Ph.D., who ran AIPM.”

As a result, he said, there’s no need to attend big meetings at resorts or in expensive hotels which tend to attract sponsorship from companies that do business in the specialty.

U.S. Pain Foundation, the largest patient advocacy group in the country, also expressed its sadness that APS is shutting down—terming it “heartbreaking.”

“There are 50 million Americans living with #pain. Hard to believe there are so few orgs left for pain providers. When providers don’t have support and resources, it hurts patients,” US Pain tweeted this week.

One critic of the opioid companies was less charitable.

Andrew Kolodny, M.D. of Physicians for Responsible Opioid Prescribing (PROP) tweeted:

“Good riddance! Despite having many members who understood opioids were lousy drugs for chronic pain, APS took millions from opioids makers, downplayed opioid risks, exaggerated opioid benefits, and lobbied against limits on opioid manufacturer,” he said.

Twillman indicated he believes the reasons for the demise of both AIPM and APS—notably the lack of support from industry and declining membership—may existentially threaten other organizations in the future.

Calls to APS offices in Chicago were not returned.

As thirty odd state AG’s suing more and more parts of those entities and businesses involved in the chronic pain disease management.  More and more are pulling back on their support of various non profits that are advocates for chronic pain treatment and in turn those organizations are losing funding and having to fold their tent.

It all started with Siobhan Reynolds and her Pain Relief Network that was “put out of business” by being targeted by law enforcement and several bureaucratic agencies .. .which in essence forced the non-profit into bankruptcy  https://www.legacy.com/obituaries/santafenewmexican/obituary.aspx?pid=155321117

Now we have two more non profit advocacy groups that are “folding their tents” because of direct/indirect actions of the various bureaucratic agencies.

Does this mean that those in the chronic pain community are ON THEIR OWN to defend their right to appropriate medications and therapies ?  Given what has happened, it is probably best that any non-profit that will be established should seek donations on a monthly basis $5 – $10 for a few million chronic painers would allow the non profit to be active and successful and not sitting on all that many dollars in reserve so that it is less attractive as a target for the bureaucrats.   They come after the non profit… the non profit sends out a notice to all those contributing to STOP… and if somehow they confiscate the $$ in reserve…  the non profit declares bankruptcy and create a new non profit because there is a legion of chronic painers willing to continue to contribute their $5-$10/month to the new non profit.  As far as the bureaucrats are concerned the agenda of the chronic painers will be like trying to catch a “greased pig”.  When the bureaucrats are using the laws against you…  you use the legal system to blunt their attempts to stop you.

A post from SIX YEARS AGO.. has anything changed for the better ?

Lilly selling half-price version of popular Humalog insulin

https://www.apnews.com/f311f61e42684838bb5fd52a4b486215

A half-price version of Eli Lilly’s popular Humalog insulin is now available, following the company’s promise in March to offer diabetics a more affordable option amid fierce criticism of soaring insulin prices.

Lilly, one of the three top insulin makers, said Wednesday that it has begun selling its own generic version of Humalog U-100 under the chemical name insulin lispro.

The Indianapolis drugmaker said insulin lispro will cost $137.35 per vial, or $265.20 for a package of five KwikPens, an easier-to-inject option.

Those figures are half the list price Lilly charges for Humalog. The fast-acting insulin, which diabetics inject shortly before each meal, is used by about 700,000 Americans.

Lilly said the biggest savings will go to patients who are uninsured, have high-deductible health insurance or have Medicare Part D plans.

Insurers generally pay drugmakers far less than the list price, but many patients must pay a percentage of the list price or the full amount until they meet their health plan’s annual deductible.

Because insulin lispro is identical to Humalog, pharmacists will be able to substitute the half-price generic. However, Lilly noted that some patients will still pay less for Humalog than insulin lispro, depending on their insurance plan.

Patients with diabetes don’t produce enough insulin to control their blood sugar, or their body uses insulin in efficiently, forcing them to inject the hormone, usually several times a day.

The average insulin price nearly tripled from 2002 through 2013, and prices have risen 10% or more a year since then, forcing many diabetics to ration their insulin. Some have ended up in hospitals and a few have died as a result, which has led to congressional hearings on the issue.

DEA: how many ways can I fine you… let me COUNT THE WAYS

DEA and U.S. Attorney in the Western District of Louisiana announce settlement with drug distributor

https://www.therolladailynews.com/news/20190524/dea-and-us-attorney-in-western-district-of-louisiana-announce-settlement-with-drug-distributor

Morris & Dickson Company LLC has agreed to pay the United States $22 million in civil penalties to resolve claims that it violated the Controlled Substances Act by failing to report suspicious orders of hydrocodone and oxycodone, announced Drug Enforcement Administration Special Agent in Charge Brad L. Byerley and United States Attorney David C. Joseph.

“The failure to report suspicious orders as required by federal regulations contributes to the opioid epidemic, which has caused devastating harm to individuals and our communities,” said Special Agent in Charge Byerley. “The settlement with Morris & Dickson demonstrates the resolve by DEA to use all available tools to address this crisis at every level and reduce the availability of highly addictive, dangerous drugs.”

“The fight against opioid abuse is among our nation’s most pressing law enforcement and public health initiatives,” said U.S. Attorney Joseph. “Opioids are now the leading cause of accidental death in the United States – killing approximately 130 Americans every day. About 40 percent of these deaths involve prescription drug abuse. This settlement demonstrates the Justice Department’s continued commitment to use all of the tools at its disposal to stem the opioid epidemic. Louisiana citizens should know that my office and our local DEA agents will continue to investigate and aggressively prosecute any manufacturer, distributor, pharmacy or doctor who, whether negligently or intentionally, fail in their duty to appropriately control the distribution and use of these deadly drugs.”

In addition to paying $22 million in settlement funds, Morris & Dickson also agreed during the course of the negotiations to make significant upgrades to its compliance program by investing millions of dollars to hire additional staff and implement new protocols and standards to ensure compliance with federal regulations requiring them to report suspicious orders of controlled substances.

This settlement arises from a DEA Office of Diversion Control investigation into Morris & Dickson’s failure to report suspicious orders of hydrocodone and oxycodone. Since January 2014, DEA Diversion agents have identified more than 12,000 allegedly suspicious retail pharmacy orders that should have been reported. Under the Controlled Substances Act and its implementing regulations, distributors are required to report suspicious orders to the DEA. Reporting suspicious orders and maintaining effective controls against diversion of controlled substances are critical components of the government’s effort to stop the illegal distribution and sale of opioids.

Morris & Dickson is the largest privately owned wholesale pharmaceutical distributor in the United States and the fourth largest wholesale distributor in the country, reporting total revenues of over $4 billion in its fiscal year ending Jan. 31, 2018. Since January 2014, Morris & Dickson distributed controlled substances to approximately 800 retail pharmacies across 17 states, distributing over 600,000,000 dosage units. Morris & Dickson services hospitals, alternative and other health care providers, and retail pharmacies out of its Shreveport, La., facility.

The Centers for Disease Control and Prevention estimates that more than 630,000 Americans died from drug overdoses from 1999 to 2016. In 2016 alone, approximately 42,000 people died of opioid-related causes. The number of opioid-overdose deaths has reached epidemic proportions: In 2016 there were five times as many such deaths as there were in 1999.

To report suspected opioid-related crimes, the public is encouraged to contact the DEA at www.deadiversion.usdoj.gov/tips_online.htm.  

 

Stool Pigeon Hyperlink ——–> www.deadiversion.usdoj.gov/tips_online.htm.  

OHIO: Overdose deaths rising this year over 2018

https://www.wdtn.com/news/local-news/overdose-deaths-trending-higher-this-year-than-2018/2021146019

DAYTON, Ohio (WDTN) – Drug overdose deaths for 2019 are out-pacing 2018, according to Montgomery County Coroner Kent Harshbarger. 

As of May 16, the coroner’s office counted 102 deaths for 2019 vs. 105 through the end of May in 2018. Harshbarger said he expected the 2019 numbers through May to be higher than 2018 once the month is finished and official reports are finished for March, April and May. 

Harshbarger said most overdose cases he’s seen are a mix of drugs in the systems of the deceased, with fentanyl being the cause of death. The drug is sometimes combined with methamphetamine or cocaine, or on some occasions, all three.

Overdose numbers are still below the numbers in 2017 with 566 for the year and 81 deaths in May 2017 alone.

The overdose surge in May 2017 was due to carefentanil, a fentanyl analog exponentially more powerful than heroin.

“A lot of the analogs are gone,” Harshbarger said. “Most are illicit fentanyl, not the prescription. We hardly ever see heroin, and if we do it’s mixed with fentanyl, cocaine or meth.” 

Harshbarger said any overdose death is alarming, but said community’s work in addressing the opioid crisis over the last several years has given people more options for help. 

“It’s certainly not as bad as 2017,” Harshbarger said. “There are more programs and more options for people in the community in need of help.” 

Benzo co-prescribed for MAT for substance abusers BUT NOT FOR CHRONIC PAINERS ?

FDA Okays Benzodiazepines and Medication-Assisted Opioid Addiction Treatment

https://www.drugtopics.com/clinical-news/fda-okays-benzodiazepines-and-medication-assisted-opioid-addiction-treatment

The FDA has issued a Drug Safety Communication on the use of benzodiazepines and opioid addiction medications. Benzodiazepines and other drugs that can depress the central nervous system do not have to be withheld from patients taking drugs such as buprenorphine or methadone for treatment of opioid addiction. However, careful medication management is needed to reduce the risks of serious side effects.

“The combined use of these drugs increases the risk of serious side effects; however, the harm caused by untreated opioid addiction can outweigh these risks,” the FDA stated in its safety communication. “Careful medication management by health-care professionals can reduce these risks.”

The new information will be added to labeling for buprenorphine and methadone, along with detailed recommendations for minimizing the use of medication-assisted treatment (MAT) drugs and benzodiazepines together. Side effects of combining opioids and benzodiazepines include dizziness or lightheadedness, extreme sleepiness, slowed or difficult breathing, or unresponsiveness.

Many people who are addicted to or dependent on opioids also take benzodiazepines or other CNS depressants either licitly to treat anxiety and other conditions or illicitly. The FDA recommends that a patient’s treatment plan should include several actions or precautions if buprenorphine or methadone are used in combination with CNS depressants. These include:

  • Educate MAT patients about the serious risks of combined use that can occur with CNS depressants.
  • Develop strategies to manage the use of prescribed or illicit benzodiazepines or other CNS depressants when starting MAT.
  • Taper the benzodiazepine or CNS depressant to discontinuation if possible.
  • Verify the diagnosis if a patient is receiving prescribed benzodiazepines or other CNS depressants for anxiety or insomnia, and considering other treatment options for these conditions.
  • Recognize that patients may require MAT medications indefinitely and their use should continue for as long as patients are benefiting and their use contributes to the intended treatment goals.
  • Coordinate care to ensure other prescribers are aware of the patient’s buprenorphine or methadone treatment.
  • Monitor for illicit drug use, including urine or blood screening.

This safety announcement is based on additional review of the use of these drugs together that caused the agency to update a previous communication. In late August 2016, the FDA had issued a strong warning against combining opioid medicines, including cough medicines, with benzodiazepines. 

NO DEAD BODIES: DEA: doctor is believed to still be over-prescribing prescription medications..office raided

Florence doctor surrendered license, prescriptions revokedFlorence doctor surrendered license, prescriptions revoked

https://www.wlbt.com/2019/05/23/florence-doctor-surrendered-license-prescriptions-revoked/

JACKSON, Miss. (WLBT) – A doctor whose Florence office was raided Monday by the Drug Enforcement Agency, the Mississippi Bureau of Narcotics, and others surrendered his license under pressure on Monday around the time his office was raided.

That’s according to the Mississippi Board of Medical Licensure. Dr. Ken Cleveland of the Board said Dr. Van Coleman has also surrendered his DEA number, which means all of his current prescriptions are no longer valid.

The investigation into Coleman started in 2018, but it was not the first time he had been under scrutiny. In 2013, he was required to take a prescribing course in lieu of being punished for failing to acknowledge that some of his patients were doctor shopping. The investigation continues, and we’re told others have also been arrested.

DEA Acting Special Agent Christopher Daniel said Coleman is believed to still be over-prescribing prescription medications.

Looking for evidence, search warrants were served on Coleman’s office in the Florence Family Medical Clinic and at his home. Authorities said he is not charged yet, but charges are forthcoming.

The Mississippi Boards of Nursing, Pharmacy, and Medical Licensure were involved with the investigation, as well as the Bureau of Alcohol Tobacco Firearms and Explosives, the Rankin County Sheriff’s Department, and the Department of Health and Human Services.